These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6119414)

  • 1. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.
    Schafer DF; Jones EA
    Lancet; 1982 Jan; 1(8262):18-20. PubMed ID: 6119414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA; Schafer DF; Ferenci P; Pappas SC
    Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
    Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA
    J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors.
    Roy S; Pomier-Layrargues G; Butterworth RF; Huet PM
    Hepatology; 1988; 8(4):845-9. PubMed ID: 2839406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure.
    Ferenci P; Covell D; Schafer DF; Waggoner JG; Shrager R; Jones EA
    Hepatology; 1983; 3(4):507-12. PubMed ID: 6862362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure].
    Jones EA; Ferenci P; Pappas SC; Schafer DF
    Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.
    Bassett ML; Mullen KD; Scholz B; Fenstermacher JD; Jones EA
    Gastroenterology; 1990 Mar; 98(3):747-57. PubMed ID: 2298374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity.
    Ferenci P; Jacobs R; Pappas SC; Schafer DF; Jones EA
    J Neurochem; 1984 May; 42(5):1487-90. PubMed ID: 6707648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies.
    Jones EA; Yurdaydin C; Basile AS
    Alcohol Alcohol Suppl; 1993; 2():175-80. PubMed ID: 7748296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gamma-aminobutyric acid (GABA) in the pathogenesis of hepatic encephalopathy].
    Riggio O; Ariosto F; Merli M; Romiti A; Varriale M; Pinto G; Pieche U; Capocaccia L
    Recenti Prog Med; 1987 Nov; 78(11):524-9. PubMed ID: 2829326
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of ammonia/gamma-aminobutyric acid (GABA) ratio for normality and liver disorders.
    Cohen BI
    Med Hypotheses; 2002 Dec; 59(6):757-8. PubMed ID: 12445521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy: a neurochemical disorder.
    Jones EA; Schafer DF
    Prog Liver Dis; 1986; 8():525-40. PubMed ID: 2872697
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the gamma-aminobutyric acid receptor-ionophore complex in seizure disorders.
    Olsen RW; Snowman AM; Lee R; Lomax P; Wamsley JK
    Ann Neurol; 1984; 16 Suppl():S90-7. PubMed ID: 6150684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gamma-Aminobutyric acid (GABA) and hepatic encephalopathy: testing the validity of electroencephalographic evidence of the GABA hypothesis.
    Myslobodsky MS
    Hepatogastroenterology; 1987 Apr; 34(2):58-64. PubMed ID: 3036678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the metabolism and binding of GABA in the rat brain in thioacetamide-induced hepatogenic encephalopathy.
    Wysmyk-Cybula U; Dabrowiecki Z; Albrecht J
    Biomed Biochim Acta; 1986; 45(3):413-9. PubMed ID: 3707558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.
    Knudsen GM; Poulsen HE; Paulson OB
    J Hepatol; 1988 Apr; 6(2):187-92. PubMed ID: 3411098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of GABA-transaminase in the blood-brain barrier to radiolabelled GABA.
    Krantis A
    Acta Neuropathol; 1984; 64(1):61-7. PubMed ID: 6475496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA, benzodiazepines and hepatic encephalopathy.
    Wilkinson SP
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):323-4. PubMed ID: 7600137
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of gamma-aminobutyric acid in anxiety.
    Enna SJ
    Psychopathology; 1984; 17 Suppl 1():15-24. PubMed ID: 6143341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.